It was recently demonstrated that intratumoral administration of dendritic cells derived from induced pluripotent stem cells (iPSCs-DCs), combined with local radiotherapy, synergistically enhances systemic antitumor immunity in poorly immunogenic mouse tumor models resistant to PD-L1 blockade [92]. Here, CD274 is linked to neoplasm.